Literature DB >> 14666696

Multiple squamous cell carcinomas of the head and neck show different phenotypes of allelic loss patterns suggesting different clonal origin of carcinogenesis.

Kiyoto Shiga1, Takenori Ogawa, Fumiaki Yoshida, Kazuto Matsuura, Masaru Tateda, Shigeru Saijo, Taeko Miyagi, Toshimitsu Kobayashi.   

Abstract

BACKGROUND: Multiple squamous cell carcinomas in the head and neck are not such a rare phenomenon in patients. To examine if these tumors have the same genetic basis or not, we investigated genetic alterations such as allelic loss in such multiple tumors to see if they showed identical patterns.
MATERIALS AND METHODS: Patterns of the loss of heterozygosity at 3p, 9p and 17p loci were analyzed in multiple head and neck squamous cell carcinomas of the same patient.
RESULTS: Metachronous laryngeal and tongue tumors of a patient were found to have identical patterns of allelic loss, while synchronous tumors of three other patients had different patterns of such loss.
CONCLUSION: Our data support the idea that field carcinogenesis caused by exposure of oral, laryngeal and pharyngeal mucosa to carcinogens may lead to the independent development of synchronous non-related tumors at different sites of the upper aerodigestive tract.

Entities:  

Mesh:

Year:  2003        PMID: 14666696

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Clonal analysis of early-stage bilateral papillary thyroid cancer identifies field cancerization.

Authors:  Xingyun Su; Shitu Chen; Kuifeng He; Zhuochao Mao; Jiaying Ruan; Jie Zhou; Xiaodong Teng; Judy Jin; Thomas J Fahey; Weibin Wang; Lisong Teng
Journal:  Endocrine       Date:  2019-02-26       Impact factor: 3.633

2.  LOH detected by microsatellite markers reveals the clonal origin of recurrent laryngeal squamous cell carcinoma.

Authors:  Zhaoyang Cui; Xinliang Pan; Qirong Wang
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.